Introduced
by
To create a state "reflex sympathetic dystrophy/complex regional pain syndrome work group" to develop public education and outreach campaigns, brochures, etc.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (H-2) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one that revises details but does not change the substance of the bill as previously described.
The substitute passed by voice vote
Amendment offered
To tie-bar the bill to House Bill 4811, meaning this bill cannot become law unless that one does also. HB 4811 would repeal Michigan's ban on suing the maker of prescription drugs that have been approved by the FDA, unless there was fraud involved.
The amendment passed by voice vote
Passed in the House 102 to 4 (details)
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one that revises details but does not change the substance of the bill as previously described.
The substitute passed by voice vote
Passed in the Senate 37 to 1 (details)
To create a state "reflex sympathetic dystrophy/complex regional pain syndrome work group" to develop public education and outreach campaigns, brochures, etc.
Passed in the House 97 to 7 (details)
To concur with the Senate-passed version of the bill.
